Clinical Trial Update: Open Label Treprostinil Raynaud's Study [Phase 4]

View source ↗

Summary

Open-label Phase 4 clinical trial of treprostinil for Raynaud's disease/phenomena is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Raynaud Disease
• Raynaud Phenomenon

Drugs mentioned

• Treprostinil (treprostinil)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Raynaud's Disease, Raynaud Phenomena | Phase 4 | Status: RECRUITING